PSAP and Parkinson disease: In PD, PSAP deficiency disrupts lipid homeostasis in dopaminergic neurons, exacerbating α-Syn aggregation [107], while reduced Sap C directly impairs β-glucocerebrosidase activity, promoting toxic protein accumulation [14].